methocarbamol structure
|
Common Name | methocarbamol | ||
---|---|---|---|---|
CAS Number | 532-03-6 | Molecular Weight | 241.240 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 472.5±40.0 °C at 760 mmHg | |
Molecular Formula | C11H15NO5 | Melting Point | 95-97ºC | |
MSDS | Chinese USA | Flash Point | 239.6±27.3 °C | |
Symbol |
GHS07, GHS08 |
Signal Word | Danger |
Use of methocarbamolMethocarbamol is a central muscle relaxant used to treat skeletal muscle spasms.Target: Carbonic AnhydraseMethocarbamol is the carbamate of guaifenesin, but does not produce guaifenesin as a metabolite, because the carbamate bond is not hydrolyzed metabolically; metabolism is by Phase I ring hydroxylation and O-demethylation, followed by Phase II conjugation. All the major metabolites are unhydrolyzed carbamates. Methocarbamol is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm [1, 2]. |
Name | Methocarbamol |
---|---|
Synonym | More Synonyms |
Description | Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms.Target: Carbonic AnhydraseMethocarbamol is the carbamate of guaifenesin, but does not produce guaifenesin as a metabolite, because the carbamate bond is not hydrolyzed metabolically; metabolism is by Phase I ring hydroxylation and O-demethylation, followed by Phase II conjugation. All the major metabolites are unhydrolyzed carbamates. Methocarbamol is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm [1, 2]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 472.5±40.0 °C at 760 mmHg |
Melting Point | 95-97ºC |
Molecular Formula | C11H15NO5 |
Molecular Weight | 241.240 |
Flash Point | 239.6±27.3 °C |
Exact Mass | 241.095016 |
PSA | 91.01000 |
LogP | 0.55 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.541 |
Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H317-H334 |
Precautionary Statements | P261-P280-P284-P304 + P340-P333 + P313-P342 + P311 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn:Harmful |
Risk Phrases | R22;R42/43 |
Safety Phrases | S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | TY8750000 |
HS Code | 2924299090 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6 |
Literature: Yakugaku Zasshi, , vol. 76, p. 880 Chem.Abstr., , p. 2625 US2770649 , ; DE1018412 , ; |
~% methocarbamol CAS#:532-03-6 |
Literature: Monatshefte fuer Chemie, , vol. 94, p. 339 - 358 |
~% methocarbamol CAS#:532-03-6
Detail
|
Literature: Journal of Organic Chemistry, , vol. 22, p. 1595,1598 |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
A new HPLC technique for the separation of methocarbamol enantiomers.
J. Pharm. Pharmacol. 51(7) , 873-5, (1999) We have developed a stereoselective high-performance liquid chromatography technique for analytical separation of methocarbamol enantiomers. Precolumn derivatization was performed at room temperature ... |
|
Spectrofluorometric determination of methocarbamol in pharmaceutical preparations and human plasma.
J. Fluoresc. 21(2) , 555-61, (2011) A simple, sensitive and rapid spectrofluorometric method for determination of methocarbamol in pharmaceutical formulations and spiked human plasma has been developed. The proposed method is based on t... |
|
A stability-indicating high-performance liquid chromatographic method for the determination of methocarbamol in veterinary preparations.
J. AOAC Int. 92(5) , 1602-5, (2009) An isocratic HPLC method was developed and validated for the quantitation of methocarbamol in the presence of its degradation products. Quantitation was achieved using a reversed-phase C18 column at a... |
Guaiacol glyceryl ether carbamate |
neuraxin |
Relax |
Methyocarbamol |
Delaxin |
2-hydroxy-3-{[2-(methyloxy)phenyl]oxy}propyl carbamate |
Relestrid |
Carbamic Acid 2-Hydroxy-3-(2-methoxyphenoxy)propyl Ester |
guaifenesin carbamate |
EINECS 208-524-3 |
2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate |
Lumirelax |
Miolaxene |
Robaxan |
Perilax |
MFCD00057662 |
methocarbamol |
Robamol |
AHR 85 |
Traumacut |
Miowas |
Robaxin |
1,2-Propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate |
Avetil |